Cargando…
Syndecan-4 as a genetic determinant of the metabolic syndrome
BACKGROUND: Syndecan-4 (SDC4) is a member of the heparan sulfate proteoglycan family of cell-surface receptors. We and others previously reported that variation in the SDC4 gene was associated with several components of the metabolic syndrome, including intra-abdominal fat, fasting glucose and trigl...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351106/ https://www.ncbi.nlm.nih.gov/pubmed/37461091 http://dx.doi.org/10.1186/s13098-023-01132-8 |
_version_ | 1785074268863725568 |
---|---|
author | Crocco, Paolina Vecchie, Denise Gopalkrishna, Sreejit Dato, Serena Passarino, Giuseppe Young, Martin E. Nagareddy, Prabhakara R. Rose, Giuseppina De Luca, Maria |
author_facet | Crocco, Paolina Vecchie, Denise Gopalkrishna, Sreejit Dato, Serena Passarino, Giuseppe Young, Martin E. Nagareddy, Prabhakara R. Rose, Giuseppina De Luca, Maria |
author_sort | Crocco, Paolina |
collection | PubMed |
description | BACKGROUND: Syndecan-4 (SDC4) is a member of the heparan sulfate proteoglycan family of cell-surface receptors. We and others previously reported that variation in the SDC4 gene was associated with several components of the metabolic syndrome, including intra-abdominal fat, fasting glucose and triglyceride levels, and hypertension, in human cohorts. Additionally, we demonstrated that high fat diet (HFD)-induced obese female mice with a Sdc4 genetic deletion had higher visceral adiposity and a worse metabolic profile than control mice. Here, we aimed to first investigate whether the mouse Sdc4 null mutation impacts metabolic phenotypes in a sex- and diet-dependent manner. We then tested whether SDC4 polymorphisms are related to the metabolic syndrome (MetS) in humans. METHODS: For the mouse experiment, Sdc4-deficient (Sdc4(−/−)) and wild-type (WT) mice were treated with 14-weeks of low-fat diet (LFD). Body composition, energy balance, and selected metabolic phenotypes were assessed. For the human genetic study, we used logistic regression models to test 11 SDC4 SNPs for association with the MetS and its components in a cohort of 274 (113 with MetS) elderly subjects from southern Italy. RESULTS: Following the dietary intervention in mice, we observed that the effects of the Sdc4 null mutation on several phenotypes were different from those previously reported in the mice kept on an HFD. Nonetheless, LFD-fed female Sdc4(−/−) mice, but not males, displayed higher levels of triglycerides and lower insulin sensitivity at fasting than WT mice, as seen earlier in the HFD conditions. In the parallel human study, we found that carriers of SDC4 rs2228384 allele C and rs2072785 allele T had reduced risk of MetS. The opposite was true for carriers of the SDC4 rs1981429 allele G. Additionally, the SNPs were found related to fasting triglyceride levels and triglyceride glucose (TyG) index, a reliable indicator of insulin resistance, with sex-stratified analysis detecting the association of rs1981429 with these phenotypes only in females. CONCLUSIONS: Altogether, our results suggest that SDC4 is an evolutionary conserved genetic determinant of MetS and that its genetic variation is associated with fasting triglyceride levels in a female-specific manner. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-023-01132-8. |
format | Online Article Text |
id | pubmed-10351106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103511062023-07-18 Syndecan-4 as a genetic determinant of the metabolic syndrome Crocco, Paolina Vecchie, Denise Gopalkrishna, Sreejit Dato, Serena Passarino, Giuseppe Young, Martin E. Nagareddy, Prabhakara R. Rose, Giuseppina De Luca, Maria Diabetol Metab Syndr Research BACKGROUND: Syndecan-4 (SDC4) is a member of the heparan sulfate proteoglycan family of cell-surface receptors. We and others previously reported that variation in the SDC4 gene was associated with several components of the metabolic syndrome, including intra-abdominal fat, fasting glucose and triglyceride levels, and hypertension, in human cohorts. Additionally, we demonstrated that high fat diet (HFD)-induced obese female mice with a Sdc4 genetic deletion had higher visceral adiposity and a worse metabolic profile than control mice. Here, we aimed to first investigate whether the mouse Sdc4 null mutation impacts metabolic phenotypes in a sex- and diet-dependent manner. We then tested whether SDC4 polymorphisms are related to the metabolic syndrome (MetS) in humans. METHODS: For the mouse experiment, Sdc4-deficient (Sdc4(−/−)) and wild-type (WT) mice were treated with 14-weeks of low-fat diet (LFD). Body composition, energy balance, and selected metabolic phenotypes were assessed. For the human genetic study, we used logistic regression models to test 11 SDC4 SNPs for association with the MetS and its components in a cohort of 274 (113 with MetS) elderly subjects from southern Italy. RESULTS: Following the dietary intervention in mice, we observed that the effects of the Sdc4 null mutation on several phenotypes were different from those previously reported in the mice kept on an HFD. Nonetheless, LFD-fed female Sdc4(−/−) mice, but not males, displayed higher levels of triglycerides and lower insulin sensitivity at fasting than WT mice, as seen earlier in the HFD conditions. In the parallel human study, we found that carriers of SDC4 rs2228384 allele C and rs2072785 allele T had reduced risk of MetS. The opposite was true for carriers of the SDC4 rs1981429 allele G. Additionally, the SNPs were found related to fasting triglyceride levels and triglyceride glucose (TyG) index, a reliable indicator of insulin resistance, with sex-stratified analysis detecting the association of rs1981429 with these phenotypes only in females. CONCLUSIONS: Altogether, our results suggest that SDC4 is an evolutionary conserved genetic determinant of MetS and that its genetic variation is associated with fasting triglyceride levels in a female-specific manner. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13098-023-01132-8. BioMed Central 2023-07-17 /pmc/articles/PMC10351106/ /pubmed/37461091 http://dx.doi.org/10.1186/s13098-023-01132-8 Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Crocco, Paolina Vecchie, Denise Gopalkrishna, Sreejit Dato, Serena Passarino, Giuseppe Young, Martin E. Nagareddy, Prabhakara R. Rose, Giuseppina De Luca, Maria Syndecan-4 as a genetic determinant of the metabolic syndrome |
title | Syndecan-4 as a genetic determinant of the metabolic syndrome |
title_full | Syndecan-4 as a genetic determinant of the metabolic syndrome |
title_fullStr | Syndecan-4 as a genetic determinant of the metabolic syndrome |
title_full_unstemmed | Syndecan-4 as a genetic determinant of the metabolic syndrome |
title_short | Syndecan-4 as a genetic determinant of the metabolic syndrome |
title_sort | syndecan-4 as a genetic determinant of the metabolic syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351106/ https://www.ncbi.nlm.nih.gov/pubmed/37461091 http://dx.doi.org/10.1186/s13098-023-01132-8 |
work_keys_str_mv | AT croccopaolina syndecan4asageneticdeterminantofthemetabolicsyndrome AT vecchiedenise syndecan4asageneticdeterminantofthemetabolicsyndrome AT gopalkrishnasreejit syndecan4asageneticdeterminantofthemetabolicsyndrome AT datoserena syndecan4asageneticdeterminantofthemetabolicsyndrome AT passarinogiuseppe syndecan4asageneticdeterminantofthemetabolicsyndrome AT youngmartine syndecan4asageneticdeterminantofthemetabolicsyndrome AT nagareddyprabhakarar syndecan4asageneticdeterminantofthemetabolicsyndrome AT rosegiuseppina syndecan4asageneticdeterminantofthemetabolicsyndrome AT delucamaria syndecan4asageneticdeterminantofthemetabolicsyndrome |